Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Optimal management of Alzheimer’s disease patients: Clinical guidelines and family advice

Authors Haberstroh J, Hampel H, Pantel J

Published 10 May 2010 Volume 2010:6(1) Pages 243—253

DOI https://doi.org/10.2147/NDT.S7106

Review by Single-blind

Peer reviewer comments 2


Julia Haberstroh, Harald Hampel, Johannes Pantel

Department of Psychiatry, Psychosomatic Medicine & Psychotherapy, Johann Wolfgang Goethe-University, Frankfurt, a.M., Germany

Abstract: Family members provide most of the patient care and administer most of the treatments to patients with Alzheimer’s disease (AD). Family caregivers have an important impact on clinical outcomes, such as quality of life (QoL). As a consequence of this service, family caregivers suffer high rates of psychological and physical illness as well as social and financial burdens. Hence, it is important to involve family caregivers in multimodal treatment settings and provide interventions that are both suitable and specifically tailored to their needs. In recent years, several clinical guidelines have been presented worldwide for evidence-based treatment of AD and other forms of dementia. Most of these guidelines have considered family advice as integral to the optimal clinical management of AD. This article reviews current and internationally relevant guidelines with emphasis on recommendations concerning family advice.
Keywords: caregivers, management, quality of life, treatment

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]